ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Eichhoff OM, Stoffel CI, Kasler J, Briker L, et al. Cancer Res 2023 Mar 22:OF1-OF19. doi: 10.1158/0008-5472.CAN-22-1826.

Read + Share

Amedeo Smart

Independent Medical Education

Eichhoff OM, Stoffel CI, Kasler J, Briker L, et al. ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer Res 2023 Mar 22:OF1-OF19. doi: 10.1158/0008-5472.CAN-22-1826.
PMID: 36946761